Risk of human immunodeficiency virus infection in multiple transfused patients
Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), G Bedarida(Ospedale Maggiore), Adriano Lazzarin(Vita-Salute San Raffaele University), Nadia Zanchetta(University of Milan), Giovanna Orando(University of Milan), Gian Piero Nardi(University of Milan)
Cited by 1
Related Papers
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173
Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy
|New England Journal of Medicine|2001|168